MGLL and pancreatic adenocarcinoma: An analysis of 44 tumors using cox regression revealed that MGLL expression was significantly positively related to the OS of UM patients (p = 1.5e-6), acute myeloid leukemia patients (LAML, p = 9.8e-4 in TCGA, p = 5.9e-3 in TARGET), and pancreatic adenocarcinoma patients (PAAD, p = 1.2e-3), but negatively related to the OS of KIRC patients (p = 1.9e-3) and sarcoma patients (SARC, p = 0.03) patients (Figure 7B).